Summit Clinical Research, LLC, a leading Integrated Research Organization (IRO) specializing in liver disease, obesity, and Alzheimer's Disease, announces the appointment of key senior leaders to drive the next phase of Summit's growth. Dr. Naim Alkhouri, MD, FAASLD, DABOM is a key opinion leader in the field of Metab…
Comac Medical, a leading full-service Contract Research Organization (CRO) in Central and Eastern Europe, announced the appointment of a new CEO and Board Chair and the launch of an international expansion initiative. Leadership Appointments Dr. Chris Smyth has been appointed as Chief Executive Officer, effective 1…
Avantor, Inc., a leading global provider of mission-critical products and services for the life sciences and advanced technology industries, announced that Michael Stubblefield intends to step down from his role as Director, President and Chief Executive Officer upon the appointment of a successor. The Board and Mr. …
Gentuity, LLC, a leader in intravascular High Frequency Optical Coherence Tomography (HF-OCT) imaging technology, is pleased to announce the strategic expansion of its senior leadership team with the addition of three highly accomplished professionals: Jason Rudy, Raj Kasbekar, and Alex Yildizyan. These key appointmen…
EnPlusOne Biosciences, Inc., a biotechnology company harnessing the power of enzymes to deliver better RNA at scale, announced the appointment of Clare Murray, Ph.D., as Chief Executive Officer. Dr. Murray brings deep experience in corporate strategy and business development, having led multiple transactions with glo…
Duke-NUS Medical School has appointed Professor Patrick Tan as its next and fourth Dean, effective 1 January 2026, marking a new chapter for the School as it builds on its legacy of medical education, research and innovation. Prof Tan will serve as Dean-designate from 1 July 2025, succeeding Professor Thomas Coffman, …
CellBio Scientific, a leading global provider of advanced tools and services for biomedical research and preclinical discovery, is excited to announce the appointment of Charles Miller as Chief Executive Officer, effective March 31, 2025. Dr. Miller will lead the company's growth following recent strategic acquisition…
Alcanza Clinical Research, a mission-focused investigator site network dedicated to reducing barriers to clinical research participation, announces the appointment of Karim Chalhoub as President and Chief Operating Officer, and Jeff Irving as Chief Financial Officer. The appointments underscore Alcanza's commitment t…
NeoGenomics, Inc. a leading oncology testing services company, announced that Tony Zook has officially assumed the role of Chief Executive Officer. “Tony has a strong command of the healthcare landscape and a deep understanding of the opportunities ahead for NeoGenomics,” said Lynn Tetrault, Chair of the Board. “His …
Ascential Medical & Life Sciences, a leader in end-to-end solutions for complex medical and life science devices that provides total commercialization services from ideation to scaled manufacturing, today announced three key executive leadership changes that will play an integral role in positioning the company fo…
Page 13 of 15